AU2001258836A1 - Preventives and remedies for pulmonary hypertension - Google Patents

Preventives and remedies for pulmonary hypertension

Info

Publication number
AU2001258836A1
AU2001258836A1 AU2001258836A AU5883601A AU2001258836A1 AU 2001258836 A1 AU2001258836 A1 AU 2001258836A1 AU 2001258836 A AU2001258836 A AU 2001258836A AU 5883601 A AU5883601 A AU 5883601A AU 2001258836 A1 AU2001258836 A1 AU 2001258836A1
Authority
AU
Australia
Prior art keywords
preventives
remedies
pulmonary hypertension
hypertension
pulmonary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258836A
Inventor
Kensuke Egashira
Yasuhiro Ikeda
Yoshiyuki Inada
Katsuo Sueishi
Yoshikazu Yonemitsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2001258836A1 publication Critical patent/AU2001258836A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
AU2001258836A 2000-05-26 2001-05-25 Preventives and remedies for pulmonary hypertension Abandoned AU2001258836A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-161145 2000-05-26
JP2000161145 2000-05-26
PCT/JP2001/004381 WO2001089582A1 (en) 2000-05-26 2001-05-25 Preventives and remedies for pulmonary hypertension

Publications (1)

Publication Number Publication Date
AU2001258836A1 true AU2001258836A1 (en) 2001-12-03

Family

ID=18665218

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258836A Abandoned AU2001258836A1 (en) 2000-05-26 2001-05-25 Preventives and remedies for pulmonary hypertension

Country Status (3)

Country Link
US (1) US7309693B2 (en)
AU (1) AU2001258836A1 (en)
WO (1) WO2001089582A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE517855T1 (en) 2001-11-30 2011-08-15 Biogen Idec Inc ANTIBODIES TO CHEMOTACTIC MONOCYTE PROTEINS
ATE469969T1 (en) * 2002-09-12 2010-06-15 Chemo Sero Therapeut Res Inst HUMAN ANTI-HUMAN MCP-1 ANTIBODIES AND ANTIBODIES FRAGMENT THEREOF
US7671037B2 (en) * 2003-02-07 2010-03-02 The Johns Hopkins University Hypoxia induced mitogenic factor
CA2544924A1 (en) * 2003-11-05 2005-05-19 Centocor, Inc. Methods and compositions for treating mcp-1 related pathologies
MX2008002101A (en) * 2005-08-12 2008-04-19 Schering Corp Mcp1 fusions.
US20080076120A1 (en) * 2006-09-14 2008-03-27 Millennium Pharmaceuticals, Inc. Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders
EP2042516A1 (en) * 2007-09-27 2009-04-01 Protaffin Biotechnologie AG Glycosaminoglycan-antagonising MCP-1 mutants and methods of using same
DK2328930T3 (en) 2008-08-20 2015-03-30 Probiodrug Ag Antibodies directed to pyroglutamate monocyte chemoattractant protein-1 (mcp-1N1pE)
US20120046218A1 (en) 2009-01-30 2012-02-23 Protaffin Biotechnologie Ag Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
US8524217B2 (en) 2010-05-11 2013-09-03 Merck Sharp & Dohme Corp. MCP1-Ig fusion variants
EP3096776B1 (en) 2014-01-22 2020-12-02 Antagonis Biotherapeutics GmbH Novel glycosaminoglycan-antagonising fusion proteins and methods of using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459128A (en) * 1993-11-12 1995-10-17 Dana-Farber Cancer Institute Human monocyte chemoattractant protein-1 (MCP-1) derivatives
US5739103A (en) * 1993-11-12 1998-04-14 Dana-Farber Cancer Institute Chemokine N-terminal deletion mutations
CA2198988A1 (en) * 1997-03-03 1998-09-03 Mai Nguyen P28 bap31 a bcl-2 associated protein and use thereof for the modulation of apoptosis
US6133502A (en) * 1997-03-10 2000-10-17 Takeda Chemical Industries, Ltd. Monocyte chemoattractant protein and its receptor transgenic animal
EP0887081B1 (en) * 1997-06-27 2003-04-23 Smithkline Beecham Corporation Human serum glucocorticoid regulated kinase, a target for chronic renal disease and diabetic nephropathy
JPH1149700A (en) * 1997-07-31 1999-02-23 Toray Ind Inc Therapeutic agent for pulmonary disease
CN100418951C (en) * 1997-11-18 2008-09-17 帝人医药株式会社 Cycloamine derivative and its use as medicine
JP2000161145A (en) * 1998-12-02 2000-06-13 Isuzu Motors Ltd Fuel injection control device for multiple cylinder engine
US20040185450A1 (en) * 2003-03-21 2004-09-23 Heavner George A. MCP-1 mutant proteins, antibodies, compositions, methods and uses
CA2544924A1 (en) * 2003-11-05 2005-05-19 Centocor, Inc. Methods and compositions for treating mcp-1 related pathologies

Also Published As

Publication number Publication date
WO2001089582A1 (en) 2001-11-29
US20030162737A1 (en) 2003-08-28
US7309693B2 (en) 2007-12-18

Similar Documents

Publication Publication Date Title
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2001251136A1 (en) Compositions and methods for promoting wound healing
AU2001261490A1 (en) Paper sizing compositions and methods
AU2002248232A1 (en) Spiral couplers
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2002215116A1 (en) Expander
AU2002224866A1 (en) Homocinetic fixed joint
AU2001292864A1 (en) Methods and compositions for modulating angiogenesis
AU2001234782A1 (en) Compositions and methods for promoting healthy joints
AU2002211717A1 (en) Stresscopins and their uses
AU2001249855A1 (en) Aqueous mineral compositions and methods for their use
AU2000241427A1 (en) Duct joint structure
AU2001295321A1 (en) Expansion joint
AU2002210925A1 (en) Preventives/remedies for portal hypertension
AU2001258836A1 (en) Preventives and remedies for pulmonary hypertension
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001232271A1 (en) Preventives/remedies for postoperative stress
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002222676A1 (en) Preventives or remedies for endometriosis
AU2001233086A1 (en) Ceramidase compositions and methods based thereon
AU5571799A (en) Angiogenesis inhibitors and uses thereof
AU2001275667A1 (en) Homocinetic joint
AU2002214681A1 (en) Hypertension
AU2002349411A1 (en) Remedies for primary pulmonary hypertension
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof